Abstract

Virulent strains of Streptococcus pyogenes (gram-positive group A Streptococcus pyogenes [GAS]) recruit host single-chain human plasminogen (hPg) to the cell surface—where in the case of Pattern D strains of GAS, hPg binds directly to the cells through a surface receptor, plasminogen-binding group A streptococcal M-protein (PAM). The coinherited Pattern D GAS-secreted streptokinase (SK2b) then accelerates cleavage of hPg at the R561-V562 peptide bond, resulting in the disulfide-linked two-chain protease, human plasmin (hPm). hPm localizes on the bacterial surface, assisting bacterial dissemination via proteolysis of host defense proteins. Studies using isolated domains from PAM and hPg revealed that the A-domain of PAM binds to the hPg kringle-2 module (K2hPg), but how this relates to the function of the full-length proteins is unclear. Herein, we use intact proteins to show that the lysine-binding site of K2hPg is a major determinant of the activation-resistant T-conformation of hPg. The binding of PAM to the lysine-binding site of K2hPg relaxes the conformation of hPg, leading to a greatly enhanced activation rate of hPg by SK2b. Domain swapping between hPg and mouse Pg emphasizes the importance of the Pg latent heavy chain (residues 1–561) in PAM binding and shows that while SK2b binds to both hPg and mouse Pg, the activation properties of streptokinase are strictly attributed to the serine protease domain (residues 562–791) of hPg. Overall, these data show that native hPg is locked in an activation-resistant conformation that is relaxed upon its direct binding to PAM, allowing hPm to form and provide GAS cells with a proteolytic surface.

Highlights

  • Plasminogen (Pg) is a 791-amino acid single-chain plasma zymogen ([Glu1]-Pg), which upon proteolytic activation to the two-chain disulfide-linked serine protease, plasmin (Pm), via cleavage at the R561V562 peptide bond and additional loss of a N-terminal 77-residue activation peptide, catalyzes the degradation of fibrin clot

  • Since mice are heavily employed as models for human disease, we focused our work on differences at the protein levels that are responsible for the disparate pathogenicities between mice and humans as related to group A Streptococcus pyogenes (GAS) infections

  • We have examined the basis of these differences between human plasminogen (hPg) and mouse Pg (mPg) through an approach that takes advantage of the well-known domainal nature of Pg, allowing the use of substitutions and exchanges of functional units of each Pg and assessment of the properties of the chimeric proteins

Read more

Summary

Introduction

Plasminogen (Pg) is a 791-amino acid single-chain plasma zymogen ([Glu1]-Pg), which upon proteolytic activation to the two-chain disulfide-linked serine protease, plasmin (Pm), via cleavage at the R561V562 peptide bond and additional loss of a N-terminal 77-residue activation peptide, catalyzes the degradation of fibrin clot. This lack of initial active site formation within the mLC prevented further activation of Pg. LBS residue D219 of hPg is critical for PAM binding

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call